Lidia Karabon

Borowska Str. 213
Wroclaw, DS 50556, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications

Cardiometabolic disease risk: the joint role of the UCP1, UCP2, UCP3, and FTO gene variants.

Cardiometabolic disease risk: the joint role of the UCP1, UCP2, UCP3, and FTO gene variants.

Journal: Biochimie
Published: June 07, 2026

Polymorphisms in immune checkpoint genes might influence bladder cancer risk and clinical outcome.

Polymorphisms in immune checkpoint genes might influence bladder cancer risk and clinical outcome.

Journal: Human immunology
Published: January 12, 2026

A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies.

A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies.

Journal: Frontiers in immunology
Published: September 23, 2025

Soluble immune checkpoints as diagnostic biomarkers in bladder cancer.

Soluble immune checkpoints as diagnostic biomarkers in bladder cancer.

Journal: Biomarker research
Published: September 19, 2025

miR-155-5p Silencing Does Not Alter BTLA Molecule Expression in CLL T Cells: Implications for Targeted Immunotherapy.

miR-155-5p Silencing Does Not Alter BTLA Molecule Expression in CLL T Cells: Implications for Targeted Immunotherapy.

Journal: Biomolecules
Published: August 29, 2025

Insights into genetic aberrations and signalling pathway interactions in chronic lymphocytic leukemia: from pathogenesis to treatment strategies.

Insights into genetic aberrations and signalling pathway interactions in chronic lymphocytic leukemia: from pathogenesis to treatment strategies.

Journal: Biomarker research
Published: June 28, 2024

Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival.

Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival.

Journal: International journal of molecular sciences
Published: May 28, 2024

BTLA biology in cancer: from bench discoveries to clinical potentials.

BTLA biology in cancer: from bench discoveries to clinical potentials.

Journal: Biomarker research
Published: September 08, 2023

Genotypes of the UCP1 gene polymorphisms and cardiometabolic diseases: A multifactorial study of association with disease probability.

Genotypes of the UCP1 gene polymorphisms and cardiometabolic diseases: A multifactorial study of association with disease probability.

Journal: Biochimie
Published: August 29, 2023

Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma.

Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma.

Journal: Journal of cancer research and clinical oncology
Published: December 21, 2022

NGS Sequencing Reveals New UCP1 Gene Variants Potentially Associated with MetS and/or T2DM Risk in the Polish Population-A Preliminary Study.

NGS Sequencing Reveals New UCP1 Gene Variants Potentially Associated with MetS and/or T2DM Risk in the Polish Population-A Preliminary Study.

Journal: Genes
Published: December 19, 2022

The Variations' in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis.

The Variations' in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis.

Journal: International journal of molecular sciences
Published: November 29, 2022
Showing 1-12 of 57

Last Updated: 09/26/2026